Document is current
Any future updates will be listed below
-
Authors
Schink, Tania
Braitmaier, Malte
Dathe, Katarina
Haug, Ulrike
Schaefer, Christof
Thöne, Kathrin
Onken, Marlies
-
Funding
Funding for this research was provided by:
Innovation Fund of the German Joint Federal Committee (01VSF16010)
Leibniz-Institut für Präventionsforschung und Epidemiologie – BIPS GmbH
- License Information
-
More Information
Article History
Received: 13 June 2025
Revised: 4 November 2025
Accepted: 25 November 2025
First Online: 17 December 2025
Declarations
:
: TS, MB, and UH are working at an independent, non-profit research institute, the Leibniz Institute for Prevention Research and Epidemiology – BIPS. Unrelated to this study, BIPS occasionally conducts post-authorization safety studies (PASS) requested by health authorities and financed by the pharmaceutical industry. These PASS are performed in line with the ENCePP Code of Conduct, which means that the design and conduct as well as the interpretation and publication are not influenced by the pharmaceutical industry. The study presented was not funded by the pharmaceutical industry. KD, MO, and CS are staff members of the Berlin Embryotox Center of Clinical Teratology and Drug Safety in Pregnancy which is financially supported by the German Federal Institute for Drugs and Medical Devices (BfArM). KT works for the Techniker Krankenkasse and has no competing interests.
